Stayble Therapeutics AB
STABL | FN
Overview
Corporate Details
- ISIN(s):
- SE0013513652 (+1 more)
- LEI:
- 549300WD23DE1US21868
- Country:
- Sweden
- Address:
- Lennart Torstenssonsgatan 6, 412 56 Göteborg
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Stayble Therapeutics AB develops injectable treatments for chronic back pain. Their solutions target the root cause of disc-related pain.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Ascelia Pharma | Sweden | ACE | |
|
Atrys Health S.A. | Spain | ATRY | |
|
AUKETT SWANKE GROUP PLC | United Kingdom | AUK | |
|
Azorean - Aquatic Technologies S.A. | Portugal | MLAAT | |
|
Bachem Holding AG | Switzerland | BANB | |
|
Bavarian Nordic | Denmark | BAVA | |
|
BB Biotech AG | Switzerland | BION | |
|
BEEKS FINANCIAL CLOUD GROUP PLC | United Kingdom | BKS | |
|
BenevolentAI | United Kingdom | BAI | |
|
BerGenBio | Norway | BGBIO |